Home

Ishita Drugs & Industries Ltd EPS

Image

Ishita Drugs & Industries Ltd

NSE: ISHITADRUGS

EPS

₹ 2.88

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Ishita Drugs & Industries Ltd is ₹ 2.88 as of 21 Feb 25 .
  • The earning per share of Ishita Drugs & Industries Ltd changed from ₹ 0.46 to ₹ 0.8 over 7 quarters. This represents a CAGR of 37.19% .

Historical Earning per Share of Ishita Drugs & Industries Ltd

No data available

* All values are in

Company Fundamentals for Ishita Drugs & Industries Ltd

Market Cap

23 Cr

EPS

2.9

P/E Ratio (TTM)

27.7

P/B Ratio (TTM)

2.3

Day’s High

79.8

Day’s Low

75.0

DTE

0.2

ROE

7.2

52 Week High

104.75

52 Week Low

56.0

ROCE

8.5

Market Price of Ishita Drugs & Industries Ltd

1M

1Y

3Y

5Y

Monitoring Ishita Drugs & Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202579.8
20 Feb 202575.75
19 Feb 202572.75
18 Feb 202572.13
17 Feb 202579
14 Feb 202575.1
13 Feb 202577
11 Feb 202575
10 Feb 202578.43
07 Feb 202580.54

BlinkX Score for Ishita Drugs & Industries Ltd

Asset Value vs Market Value of Ishita Drugs & Industries Ltd

Market Value

24

Asset Value

Value addition

2.6 X

7

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Ishita Drugs & Industries Ltd23.86
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Ishita Drugs & Industries Ltd

No data available

* All values are in crore

Historical Revenue of Ishita Drugs & Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Ishita Drugs & Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Ishita Drugs & Industries Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Ishita Drugs & Industries Ltd News Hub

Ishita Drugs & Industries standalone net profit rises 7.14% in the June 2024 quarter

Net profit of Ishita Drugs & Industries rose 7.14% to Rs 0.15 crore in the quarter ended June 2024 a

Read more

14 Aug 24

Ishita Drugs & Industries to declare Quarterly Result

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 August

Read more

10 Aug 24

Ishita Drugs & Industries AGM scheduled

Ishita Drugs & Industries announced that the Annual General Meeting (AGM) of the company will be hel

Read more

28 Aug 24

Ishita Drugs & Industries standalone net profit declines 9.52% in the September 2024 quarter

Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended Septemb

Read more

13 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Ishita Drugs & Industries Ltd

What is the EPS of Ishita Drugs & Industries Ltd stock?

The Earnings Per Share (EPS) of Ishita Drugs & Industries Ltd is 2.88. An EPS is the amount of net income attributed to each share of a common stock.

How is Ishita Drugs & Industries Ltd EPS calculated?

The EPS of Ishita Drugs & Industries Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Ishita Drugs & Industries Ltd report its EPS?

Ishita Drugs & Industries Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Ishita Drugs & Industries Ltd EPS?

Factors that influence the EPS of Ishita Drugs & Industries Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Ishita Drugs & Industries Ltd EPS growth indicate future performance?

Yes, consistent growth in Ishita Drugs & Industries Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions